Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hologic CE marks Adiana contraceptive

This article was originally published in Clinica

Executive Summary

Hologic has CE marked its radiofrequency-based Adiana permanent contraception system for sale in Europe. The transcervical Adiana procedure uses a bi-polar radiofrequency energy catheter to remove cells lining a 1cm section of the inside of the fallopian tube. The catheter then delivers a soft polymer implant into the prepared section of the tube. The procedure is repeated on the other tube. The procedure is designed such that healthy tissue will grow into the matrix to create a complete blockage of each tube. The device is awaiting approval in the US, Canada and Australia, Bedford, Massachusetts-based Hologic said.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043224

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel